Previously submitted to: JMIR Public Health and Surveillance (no longer under consideration since Jul 12, 2023)
Date Submitted: May 21, 2022
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Metabolic syndrome among patients with type 2 diabetes in Jordan: A cross-sectional study
ABSTRACT
Background:
Metabolic syndrome is one of the major public health problems worldwide and it is an independent predictor of cardiovascular disease in patients with type 2 diabetes (T2DM).
Objective:
This study aimed to determine the prevalence of metabolic syndrome and its individual components among patients with T2DM.
Methods:
A cross-sectional design was conducted among patients diagnosed with T2DM at the National Center for Diabetes and Endocrinology, Jordan. Data were collected using a structured questionnaire and clinical data were extracted from medical records. The National Cholesterol Education Program-Adult Treatment Panel III (ATP III) and International Diabetes Federation (IDF) diagnostic criteria were used to define metabolic syndrome.
Results:
A total of 1017 participants aged between 22-90 year were included in the study. The overall prevalence of the IDF defined metabolic syndrome was 84.2% (72.5% among males and 96.2% among females). Using ATP III criteria, the overall prevalence of the metabolic syndrome was 79.1 (77.4% among males and 80.8% among females). Increased age, female gender, not adherent to diet regimen, sedentary lifestyle or insufficient physical activity, and duration of diabetes ≥ 10 year were significantly associated with increased odds of metabolic syndrome, regardless of definition used. Current smoking status and family history of cardiovascular diseases were significantly associated with increased likelihood of ATP III defined metabolic syndrome.
Conclusions:
The prevalence of metabolic syndrome among patients with diabetes is extremely high. The main modifiable risk factors of metabolic syndrome among patients with diabetes include non-adherence to diet regimen, insufficient physical activity, overweight or obesity and smoking. It is recommended that healthcare providers council patients on the importance of maintaining physical activity, quitting smoking and adherence to diet regimen.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.